A complete genomic screen for multiple sclerosis underscores a role for the major histocompatability complex
Haines, J.L, Ter-Minassian, M, Bazyk, A, Gusella, J.F, Kim, D.J, Terwedow, H, PericakVance, M.A, Rimmler, J.B, Haynes, C.S, Roses, A.D, Lee, A, Shaner, B, Menold, M, Seboun, E, Fitoussi, R-P, Gartioux, C, Reyes, C, Ribierre, F, Gyapay, G, Weissenbach, J, Hauser, S.L, Goodkin, D.E, Lincoln, R, Usuku, K, Garcia-Merino, A, Gatto, N, Young, S, Oksenberg, J.R
Published in Nature genetics (01.08.1996)
Published in Nature genetics (01.08.1996)
Get full text
Journal Article
Long-term reduction of relapse rate and confirmed disability progression after 6 years of ocrelizumab treatment in patients with relapsing multiple sclerosis
Giovannoni, G., Kappos, L., Hauser, S.L., Montalban, X., Koendgen, H., Prajapati, K., Manfrini, M., Mehta, L., Wolinsky, J.
Published in Journal of the neurological sciences (15.10.2019)
Published in Journal of the neurological sciences (15.10.2019)
Get full text
Journal Article
P61 Sustained reduction in confirmed disability progression in patients with primary progressive multiple sclerosis treated with ocrelizumab in the open-label extension period of the Phase III ORATORIO trial
Wolinsky, J.S., Hartung, H.P., Brochet, B., Montalban, X., Naismith, R.T., Manfrini, M., Garas, M., Model, F., Hubeaux, S., Kappos, L., Hauser, S.L.
Published in Clinical neurophysiology (01.08.2019)
Published in Clinical neurophysiology (01.08.2019)
Get full text
Journal Article
P60 Long-term reduction of relapse rate and confirmed disability progression after 5 years of ocrelizumab treatment in patients with relapsing multiple sclerosis
Hauser, S.L., Hartung, H.P., Brochet, B., Montalban, X., Naismith, R.T., Wolinsky, J.S., Manfrini, M., Garas, M., Model, F., Hubeaux, S., Kappos, L.
Published in Clinical neurophysiology (01.08.2019)
Published in Clinical neurophysiology (01.08.2019)
Get full text
Journal Article
Neurite Orientation Dispersion and Density Imaging for Assessing Acute Inflammation and Lesion Evolution in MS
Sacco, S, Caverzasi, E, Papinutto, N, Cordano, C, Bischof, A, Gundel, T, Cheng, S, Asteggiano, C, Kirkish, G, Mallott, J, Stern, W A, Bastianello, S, Bove, R M, Gelfand, J M, Goodin, D S, Green, A J, Waubant, E, Wilson, M R, Zamvil, S S, Cree, B A, Hauser, S L, Henry, R G
Published in American journal of neuroradiology : AJNR (01.12.2020)
Published in American journal of neuroradiology : AJNR (01.12.2020)
Get full text
Journal Article
A genome-wide association study of brain lesion distribution in multiple sclerosis
GOURRAUD, Pierre-Antoine, SDIKA, Michael, KHANKHANIAN, Pouya, HENRY, Roland G, BEHESHTIAN, Azadeh, MATTHEWS, Paul M, HAUSER, Stephen L, OKSENBERG, Jorge R, PELLETIER, Daniel, BARANZINI, Sergio E
Published in Brain (London, England : 1878) (01.04.2013)
Published in Brain (London, England : 1878) (01.04.2013)
Get full text
Journal Article
2D phase-sensitive inversion recovery imaging to measure in vivo spinal cord gray and white matter areas in clinically feasible acquisition times
Papinutto, Nico, Schlaeger, Regina, Panara, Valentina, Caverzasi, Eduardo, Ahn, Sinyeob, Johnson, Kevin J., Zhu, Alyssa H., Stern, William A., Laub, Gerhard, Hauser, Stephen L., Henry, Roland G.
Published in Journal of magnetic resonance imaging (01.09.2015)
Published in Journal of magnetic resonance imaging (01.09.2015)
Get full text
Journal Article
P 1 Effect of ocrelizumab on magnetic resonance imaging markers of neurodegeneration in patients with relapsing multiple sclerosis – analysis of the phase III, double-blind, double-dummy, interferon beta-1a- controlled OPERA I and OPERA II studies
Ziemssen, T., Arnold, D.L., Bar-Or, A., Comi, G., Hartung, H.P., Hauser, S.L., Kappos, L., Lublin, F., Selmaj, K., Traboulsee, A., Masterman, D., Chin, P., Garren, H., Wolinsky, J.S.
Published in Clinical neurophysiology (01.10.2017)
Published in Clinical neurophysiology (01.10.2017)
Get full text
Journal Article
P 2 Effect of ocrelizumab on humoral immunity markers in the phase iii, double-blind, double-dummy, IFN[formula omitted]-1a–controlled OPERA I and OPERA II studies
Ziemssen, T., Bar-Or, A., Arnold, D.L., Comi, G., Hartung, H.P., Hauser, S.L., Lublin, F., Selmaj, K., Traboulsee, A., Chin, P., Fontoura, P., Garren, H., Masterman, D., Kappos, L.
Published in Clinical neurophysiology (01.10.2017)
Published in Clinical neurophysiology (01.10.2017)
Get full text
Journal Article
P 2 Effect of ocrelizumab on humoral immunity markers in the phase iii, double-blind, double-dummy, IFN β -1a–controlled OPERA I and OPERA II studies
Ziemssen, T., Bar-Or, A., Arnold, D.L., Comi, G., Hartung, H.P., Hauser, S.L., Lublin, F., Selmaj, K., Traboulsee, A., Chin, P., Fontoura, P., Garren, H., Masterman, D., Kappos, L.
Published in Clinical neurophysiology (01.10.2017)
Published in Clinical neurophysiology (01.10.2017)
Get full text
Journal Article
Vitamin D in African Americans with multiple sclerosis
Gelfand, J M, Cree, B A C, McElroy, J, Oksenberg, J, Green, R, Mowry, E M, Miller, J W, Hauser, S L, Green, A J
Published in Neurology (24.05.2011)
Published in Neurology (24.05.2011)
Get more information
Journal Article
Safety of Ocrelizumab in Multiple Sclerosis: Updated Analysis in Patients with Relapsing and Primary progressive Multiple Sclerosis
Hauser, S.L., Kappos, L., Montalban, X., Hughes, R., Koendgen, H., McNamara, J., Pradhan, A., WorMSer, D., Wolinsky, J.S.
Published in Multiple sclerosis and related disorders (01.11.2018)
Published in Multiple sclerosis and related disorders (01.11.2018)
Get full text
Journal Article
Multiple sclerosis susceptibility alleles in African Americans
Johnson, B A, Wang, J, Taylor, E M, Caillier, S J, Herbert, J, Khan, O A, Cross, A H, De Jager, P L, Gourraud, P-A F, Cree, B C A, Hauser, S L, Oksenberg, J R
Published in Genes and immunity (01.06.2010)
Published in Genes and immunity (01.06.2010)
Get full text
Journal Article
Genetic burden in multiple sclerosis families
Isobe, N, Damotte, V, Re, V Lo, Ban, M, Pappas, D, Guillot-Noel, L, Rebeix, I, Compston, A, Mack, T, Cozen, W, Fontaine, B, Hauser, S L, Oksenberg, J R, Sawcer, S, Gourraud, P-A
Published in Genes and immunity (01.10.2013)
Published in Genes and immunity (01.10.2013)
Get full text
Journal Article
Long-term Reduction of Relapse Rate and Confirmed Disability progression after 5 years of Ocrelizumab Treatment in Patients with Relapsing Multiple Sclerosis
Hauser, S.L., Brochet, B., Montalban, X., Naismith, R.T., Wolinsky, J.S., Manfrini, M., Garas, M., Villoslada, P., Model, F., Hubeaux, S., Kappos, L.
Published in Multiple sclerosis and related disorders (01.11.2018)
Published in Multiple sclerosis and related disorders (01.11.2018)
Get full text
Journal Article
Long-term Reduction in Brain MRI Disease Activity and Atrophy after 5 years of Ocrelizumab Treatment in Patients with Relapsing Multiple Sclerosis
Arnold, D.L., Kappos, L., Hauser, S.L., Montalban, X., Traboulsee, A., Wolinsky, J.S., Manfrini, M., Levesque, V., Villoslada, P., Belachew, S., Model, F., Hubeaux, S., Bar-Or, A.
Published in Multiple sclerosis and related disorders (01.11.2018)
Published in Multiple sclerosis and related disorders (01.11.2018)
Get full text
Journal Article
Sustained Reduction in Confirmed Disability Progression in Patients with Primary Progressive Multiple Sclerosis Treated with Ocrelizumab in the Open-label Extension Period of the Phase III ORATORIO trial
Hauser, S.L., Wolinsky, J.S., Brochet, B., Montalban, X., Naismith, R.T., Manfrini, M., Garas, M., Villoslada, P., Model, F., Hubeaux, S., Kappos, L.
Published in Multiple sclerosis and related disorders (01.11.2018)
Published in Multiple sclerosis and related disorders (01.11.2018)
Get full text
Journal Article
HLA-DR2 Dose Effect on Susceptibility to Multiple Sclerosis and Influence on Disease Course
Barcellos, L.F., Oksenberg, J.R., Begovich, A.B., Martin, E.R., Schmidt, S., Vittinghoff, E., Goodin, D.S., Pelletier, D., Lincoln, R.R., Bucher, P., Swerdlin, A., Pericak-Vance, M.A., Haines, J.L., Hauser, S.L.
Published in American journal of human genetics (01.03.2003)
Published in American journal of human genetics (01.03.2003)
Get full text
Journal Article
A knowledge-driven interaction analysis reveals potential neurodegenerative mechanism of multiple sclerosis susceptibility
Bush, W S, McCauley, J L, DeJager, P L, Dudek, S M, Hafler, D A, Gibson, R A, Matthews, P M, Kappos, L, Naegelin, Y, Polman, C H, Hauser, S L, Oksenberg, J, Haines, J L, Ritchie, M D
Published in Genes and immunity (01.07.2011)
Published in Genes and immunity (01.07.2011)
Get full text
Journal Article
SNP-based analysis of the HLA locus in Japanese multiple sclerosis patients
McElroy, J P, Isobe, N, Gourraud, P A, Caillier, S J, Matsushita, T, Kohriyama, T, Miyamoto, K, Nakatsuji, Y, Miki, T, Hauser, S L, Oksenberg, J R, Kira, J
Published in Genes and immunity (01.10.2011)
Published in Genes and immunity (01.10.2011)
Get full text
Journal Article